Cook Medical Technologies LLC

Other

Cook Biotech, Inc.

S.l.a. Pharma Ag

Cook Incorporated

David Nigel Armstrong

Umesh H Patel

F Joseph Obermiller

Mark W Bleyer

Brian L Bates

Justin Slagel

Michael Robert Armstrong

Brain L Bates

A topical composition comprising about 5 wt % to about 12.5 wt % of metronidazole or a pharmacologically acceptable salt thereof in a non-aqueous vehicle. The composition may be used in the treatment of skin damage due to inflammatory skin conditions; thermal, chemical or electrical burns; infections or radiation treatment. One advantage of the composition is that topical administration of metronidazole results in a primarily local effect, and thus, side effects observed from systemic administration are avoided.

Topical pharmaceutical compositions for treatment of pilonidal sinus wounds

A topical composition comprises at least 5 wt % metronidazole or a pharmacologically acceptable derivative thereof in a non-aqueous vehicle. The composition may be used in the treatment of conditions of the colon, rectum, anorectum and perianal region, in particular inflammatory bowel disease and perianal Crohn's disease. The composition also relieves pain and inflammation and promotes healing of the colon, rectum, anorectum and perianal region following surgical operations. One advantage of the composition is that topical administration of metronidazole results in a primarily local effect and thus side effects observed from systemic administration are avoided.

Pharmaceutical composition

Topical pharmaceutical compositions for treatment of skin damage

A topical composition comprises at least 5-wt % metronidazole or a pharmacologically acceptable derivative thereof in a non-aqueous vehicle. The composition may be used in the treatment of conditions of the colon, rectum, anorectum and perianal region, in particular inflammatory bowel disease and perianal Crohn's disease. The composition also relieves pain and inflammation and promotes healing of the colon, rectum, and anorectum and perianal region following surgical operations. One advantage of the composition is that topical administration of metronidazole results in a primarily local effect and thus side effects observed from systemic administration are avoided.

An implantable graft, which may be inserted into a fistula tract to occlude the primary opening of the fistula, is provided. The graft may have a curved, generally conical shape with a trumpet-like head end that continuously tapers to a smaller tail end. The graft may be an integral unit made of a single material, such as a heterograft material. Methods of closing single and multiple fistulae are also provided.

Implantable graft to close a fistula

Systems, devices, and methods capable of retracting organs are disclosed. In one embodiment, a retractor body comprises a deformable resilient frame defining a central opening and a deformable membrane extending across a portion of the central opening wherein the deformable resilient frame is arranged for complete disposal within the body of a patient and for varying the size of the central opening. In some exemplary embodiments, the retractor is arranged to form a helically coiled arrangement for insertion into the body of a patient. Delivery devices for delivering a deformable resilient retractor and methods of delivery are also disclosed.

Surgical retractor device

An implantable graft, which may be inserted into a fistula tract to occlude the primary opening of the fistula, is provided. To prevent unintentional displacement of the graft or extrusion of the graft from the fistula of a patient, the graft may be provided with a cap that extends laterally from at least one end of the body of the graft, where the cap may be integral with the body of the graft, attachable to at least one end of the body of the graft, and/or moveable along the body of the graft. The graft may also have a tail that extends from one end of the body of the graft to assist in placement of the graft in a fistula tract. The graft may be an integral unit made of a single material, such as a heterograft material, or may include distinct components made of the same or different materials. Methods for closing a fistula tract are also provided.

A fiber-optic endoscopic instrument (Fistuloscope) is used to visualize anorectal fistula, and to accurately identify the course through the fistula. The instrument can be used to flush the fistula, to close the fistula tract by means of injecting sealants or placing grafts in the tract of the fistula or to pass setons, micro-instruments or other means to treat and seal the tract.

Instrument and method for endoscopic visualization and treatment of anorectal fistula

A hemorrhoidal ligator and anoscope system used to facilitate ligation of internal hemorrhoids. The ligating device consists of head, shaft and firing handle assemblies and is capable of storing and releasing multiple rubber bands singularly. The ligating device comprises an inner cylinder that is removable for disposal or reloading for reuse. The inner cylinder may also be configured with a disposable sleeve, the sleeve being disposable or capable of reloading. A modified loading cone is provided for facilitating loading of the rubber bands onto the inner cylinder or the inner cylinder sleeve. The anoscope is configured with three lateral apertures that coincide with the anatomic locations of the internal hemorrhoids in man and thus, simultaneously expose all three hemorrhoids for ligation and grading.

Multiple band ligator and anoscope system and method for using same

A pair of sensors ( A and B) are mounted at the entrance to a germ sensitive area. When a person enters the area the sensors are activated in sequence, indicating the direction of movement of the person. An indicator, such as a light or sound alarm is mounted upon an antiseptic dispenser, located within the area. The alarm is actuated by the movement and is de-activated once antiseptic is dispensed from the unit. Likewise when the person moves out of the germ sensitive area, the alarm on a dispenser unit located outside the area is energized and is de-activated upon dispensing of antiseptic.

Hand antiseptic system and method

A combined door carrier and hanging device for transporting and hanging a door panel is provided. The combined device is generally defined by an elongated carrier structure having a first end and a second end, and includes a wheel supporting chassis to which a pair of beams are mounted and spaced apart to define an elongated slot. The chassis further supports a plurality of floor engaging foot members at the second end, a vise mechanism at the second end, and an axle having a plurality of floor engaging wheels at the first end. More specifically, the elongated slot is adapted to closely receive a door panel across its thickness, wherein one of the pair of beams is rigidly attached the chassis at the first end, but is free to flex at the second end to facilitate clamping of a door panel in the slot. The vise mechanism is attached to the chassis at the second end, which vise when operated compresses the second end of one beam moving the beam toward the other beam, thereby narrowing the slot and hence clamping upon a panel placed therein.

Growing community of inventors

Atlanta, GA, United States of America

David Nigel Armstrong